TWST Twist Bio: תחזית צמיחת רווח נקי למניה לשנה הבאה

Twist Bioscience (TWST) has secured immense industry trust through its status as a DNA synthesis revolutionary, which is further validated by a promising valuation of net profit dynamics. Market dominance is sustained by a unique silicon-based printing process that creates significant pricing power. Simultaneously, this chip-based method radically reduces resource consumption, aligning with ESG principles. The value of 38.60 corresponds to the current analyst yield expectation metric.

To find fundamental support for Twist Bioscience (TWST) assets, it is essential to analyze the forward earnings growth forecast, which reflects the analysts' consensus estimate for EPS changes in the coming year. This indicator measures the expected net income trend, allowing for an assessment of how explosive demand for synthetic DNA and ARR growth can reduce current losses and bring the company closer to the break-even point.